Condiciones de salud que pimienta negra puede ayudar a apoyar.
Piperine enhances iron bioavailability by modifying intestinal epithelial cell membrane dynamics and stimulating brush border membrane enzyme activity, facilitating iron transport. A MDPI Nutrients (2020) review proposed piperine (BioPerine) as a potential adjunct in iron-deficiency management. Effect is indirect—as an absorption enhancer rather than an iron source.
Piperine scavenges free radicals, inhibits lipid peroxidation, and upregulates endogenous antioxidant enzymes. Human RCTs using curcumin-piperine combinations show improvements in superoxide dismutase, total antioxidant capacity, and malondialdehyde in metabolic syndrome and chronic disease populations. A 2026 systematic review of 15 RCTs found 12 showed measurable improvements in oxidative stress markers.
A small human study found that a beverage containing black pepper reduced appetite compared to plain water. Piperine may also modulate appetite indirectly through thermogenic and metabolic effects. Traditional Ayurvedic medicine uses black pepper specifically to stimulate low appetite.
Piperine inhibited IL-6, MMP13, COX-2, and PGE2 in human rheumatoid arthritis synoviocytes in vitro in a dose-dependent manner. In animal arthritis models it significantly reduced inflammation, nociception, and joint inflammatory area. A curcumin-piperine human RCT also documented antioxidant improvements in 40 osteoarthritis patients.
Piperine has demonstrated antihypertensive properties in animal models and indirect support from human RCTs. A 12-week curcumin-piperine RCT in stroke rehabilitation patients found significant reductions in both systolic and diastolic blood pressure. Piperine is widely documented to have antihypertensive pharmacological activity.
Piperine inhibits intestinal alpha-glucosidases, potentially slowing post-meal glucose absorption, and may activate the CaMKKβ/AMPK pathway to promote GLUT4-mediated glucose uptake. Animal data are consistent, and some human RCTs using curcumin-piperine combinations document reductions in fasting blood glucose and HbA1c. Isolated piperine human trials are limited.
Piperine inhibits intestinal cholesterol transporter proteins NPC1L1 and SR-BI, reducing cholesterol uptake. A 2025 double-blind RCT in 170 NAFLD patients found piperine supplementation produced a 15% reduction in total cholesterol and a 22% reduction in LDL. A 2026 meta-analysis of RCTs confirmed significant total cholesterol and LDL reductions, particularly with turmeric-piperine combinations.
Piperine, the primary alkaloid in black pepper, inhibits key pro-inflammatory mediators including COX-2, IL-6, and prostaglandin E2. Multiple human RCTs using curcumin-piperine combinations have documented significant reductions in CRP, hs-CRP, and IL-6 in metabolic syndrome and other inflammatory conditions. A 2026 systematic review of 20 RCTs found 15 showed significant decreases in inflammatory biomarkers.
A 2023 comprehensive review in Aging and Disease (PMC) documents that piperine and other black pepper bioactive compounds show neuroprotective effects across multiple age-related neurological disorder models including Alzheimer's, Parkinson's, and Huntington's disease. Evidence is predominantly preclinical but mechanistically robust.
Piperine exhibited antidepressant-like effects in animal models, reducing immobility and raising serotonin precursor (5-HTP) levels. In silico analysis identified multiple black pepper bioactive compounds with antidepressant activity via interaction with target proteins. MAO-B inhibition provides a plausible antidepressant mechanism. All meaningful evidence remains preclinical.
Piperine stimulates pancreatic digestive enzyme secretion (amylase, lipase, proteases) and activates brush border membrane enzymes in the jejunum, enhancing nutrient breakdown and absorption. These effects have been documented in both animal studies and human pharmacological research, providing mechanistic backing for traditional use as a digestive stimulant.
Research published in Evidence-Based Complementary and Alternative Medicine examined how black pepper (alongside turmeric, ginger, and long pepper) alters the gut microbiome composition. Black pepper promoted measurable shifts in gut bacteria associated with health, consistent with its 5,000+ year traditional use as a digestive herb in Ayurveda.
Piperine inhibits adipogenesis (new fat cell formation), activates thermogenesis via catecholamine release, and may modestly reduce appetite. Multiple animal studies document reductions in body fat. Human evidence is preliminary and mostly indirect via metabolic syndrome RCTs reporting reduced waist circumference and weight alongside lipid improvements.
Black pepper and piperine favorably modulate multiple cardiovascular risk factors including LDL cholesterol, triglycerides, CRP, and blood pressure. An RCT in stroke patients found 12-week curcumin-piperine supplementation reduced carotid intima-media thickness and systolic/diastolic blood pressure alongside lipid improvements.
Multiple mechanisms—AMPK activation, GLUT4 upregulation, and anti-inflammatory actions reducing metabolic inflammation—underpin piperine's insulin-sensitizing effects. Animal studies consistently show improved insulin tolerance, and human data (largely via curcumin-piperine RCTs) report reduced HOMA-IR. Direct piperine-only human evidence remains sparse.
Piperine has demonstrated hepatoprotective activity by reducing lipid peroxidation, preventing GSH depletion, and inhibiting hepatotoxin-induced enzyme leakage in animal models. A human pilot study found piperine-curcumin-taurine combination benefited hepatocellular carcinoma patients. Traditional medicine systems have long used black pepper for liver and biliary complaints.
Piperine demonstrated cognitive-enhancing effects in streptozotocin-induced rat models of Alzheimer's-type dementia and scopolamine-induced cognitive deficit. It protects hippocampal neurons, inhibits neuroinflammation, and crosses the blood-brain barrier. Human evidence is currently absent; all meaningful evidence is preclinical.
Black pepper's active alkaloid piperine has been studied in human clinical trials for effects on metabolic parameters including lipid profiles, glycemic indices, and inflammatory markers. A 2023 PMC systematic review found clinical evidence that piperine reduces total cholesterol, LDL-C, and triglycerides in overweight and obese individuals. Mechanistically, piperine activates the AMPK signaling pathway in skeletal muscle, upregulates UCP1, and modulates PPARγ activity—all pathways central to energy and lipid metabolism. Evidence quality is moderate: most positive human trials use piperine in combination (particularly with curcumin), making piperine's independent contribution harder to isolate.
Piperine inhibits MAO-B (the enzyme that degrades dopamine), crosses the blood-brain barrier, and protects dopaminergic neurons in multiple animal and cell models of Parkinson's disease. In rotenone-induced neurotoxicity models, piperine restored mitochondrial function in neuronal cells. Evidence is entirely preclinical.
Piperine stimulates catecholamine release in intestinal epithelial cells, triggering a cAMP-mediated thermogenic response. This thermogenic action is one of its primary mechanisms as a bioavailability enhancer branded as BioPerine. It is well-characterized mechanistically, though the magnitude and duration of thermogenic effect in humans are modest.
Human RCT evidence, including a 2025 double-blind trial in 170 NAFLD patients, demonstrates substantial triglyceride reductions with piperine supplementation. A 2026 meta-analysis confirmed pooled triglyceride reductions across RCTs. Animal models corroborate these findings consistently.
Multiple clinical studies in vitiligo patients have demonstrated that topical piperine, alone or combined with narrowband UVB phototherapy, stimulates melanocyte proliferation and repigmentation. Topical black pepper extract outperformed pure piperine in one 12-week trial. Human clinical evidence for this indication is the strongest among dermatological applications.
Black pepper has an extensively documented traditional use across Ayurvedic, traditional Chinese, and Unani medicine systems for abdominal discomfort including bloating, flatulence, and digestive sluggishness. Piperine's digestive enzyme stimulation and gut motility effects provide plausible mechanistic support, though direct human RCT evidence targeting abdominal discomfort as a primary endpoint is lacking.
Black pepper is classified in Ayurveda and traditional Chinese medicine as a warming, circulatory-stimulant herb. The Trikatu formula including black pepper is specifically indicated for stimulating circulation. Modern pharmacological data on piperine's cardiovascular effects (blood pressure, lipid profiles) provide partial mechanistic support.
Black pepper has an extensive history of traditional use across Ayurvedic, traditional Chinese, and folk medicine systems for cold and flu symptoms, valued for its warming, antimicrobial, and immune-stimulating properties. Piperine's documented immunomodulatory, antimicrobial, and anti-inflammatory activities provide mechanistic plausibility.
Black pepper is used in Ayurvedic and traditional medicine as a digestive stimulant that reduces gastrointestinal transit time. Piperine has been documented to enhance gut motility in pharmacological studies, reducing food transit time.
Black pepper is documented in Ayurvedic, Unani, and traditional Chinese medicine as an antidiarrheal agent with antispasmodic properties. Piperine's antidiarrheal and antispasmodic pharmacological activities are listed in pharmacological reviews, supported by animal data.
Black pepper is used in Ayurvedic and traditional South and Southeast Asian medicine for fever management, particularly for cold-type or damp fevers associated with phlegm and sluggish digestion. Its diaphoretic (sweat-promoting) traditional action is part of the rationale.
Black pepper is used in Ayurveda, TCM, and Western herbal traditions as an expectorant and mucolytic for sticky, excess mucus and phlegm. The Trikatu formula specifically addresses lung problems accompanied by sticky mucus. Piperine's irritant and thermogenic actions on respiratory mucosa are proposed mechanisms.
Black pepper is used in various traditional medicine systems including Ayurveda for nausea and vomiting, often combined with ginger. Its antiemetic use is documented in traditional contexts, though scientific human trial evidence specifically for this indication is absent.
Black pepper is used in Ayurvedic, traditional Chinese, and folk medicine as a decongestant and sinus-clearing agent. Its pungent irritant action stimulates nasal secretion and may temporarily open nasal passages. Piperine activates TRPV1 channels in nasal mucosa, providing mechanistic plausibility.
Black pepper mixed with honey or warm liquid is a widely documented traditional remedy for sore throat across Ayurvedic, folk, and traditional Chinese medicine. Its antimicrobial, anti-inflammatory, and mild analgesic properties provide mechanistic plausibility.
Volver